EMR
64
5
VTR
67
-3
THC
47
2
NSC
48
-11
TDC
70
3
HSY
43
2
WHR
50
-5
BRK.B
33
-14
OXY
40
2
PNW
53
-3
CFG
95
2
CCI
36
2
CAT
58
-8
ILMN
73
4
AME
72
6
TXT
82
4
NOV
52
4
ETR
47
-2
LYB
22
2
DHR
66
2
EMR
64
5
VTR
67
-3
THC
47
2
NSC
48
-11
TDC
70
3
HSY
43
2
WHR
50
-5
BRK.B
33
-14
OXY
40
2
PNW
53
-3
CFG
95
2
CCI
36
2
CAT
58
-8
ILMN
73
4
AME
72
6
TXT
82
4
NOV
52
4
ETR
47
-2
LYB
22
2
DHR
66
2
Financhill
Back

Royal Gold, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
76

RGLD
Royal Gold, Inc.

Last Price:
$227.59
Seasonality Move:
14.19%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Buy
76
Royal Gold, Inc. (RGLD) is a Buy

Is Royal Gold, Inc. a Buy, Sell or Hold?

  • The current Royal Gold, Inc. [RGLD] share price is $227.64. The Score for RGLD is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • RGLD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGLD Stock Price Chart

What is Royal Gold, Inc.'s stock price today?

  • The Royal Gold, Inc. share price today is $227.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGLD is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

RGLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 42.3 Buy
Relative Strength Index (14 RSI): 75.32 Buy
Chaikin Money Flow: 530171 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (189.09 - 215.95) Buy
Bollinger Bands (100): (172.51 - 203.29) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

RGLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 219.29 Buy
20-day SMA: 206.77 Buy
50-day SMA: 193.85 Buy
200-day SMA: 178.99 Buy
8-day EMA: 119.11 Buy
20-day EMA: 58.28 Buy
50-day EMA: 25.4 Buy
200-day EMA: 6.64 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Royal Gold, Inc. Earnings Growth & RGLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.93 per share, and an increase next year of $3.38 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Royal Gold, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):